date:Feb 11, 2014
s website on Jan 29 that it had filed an application of clinical trials for its H7N9 vaccine products.
Liu said it's possible that if H7N9 cases were to flare, the testing process would accelerate.
In 2009, when human infections of H1N1 were frequently reported, the CFDA raised the priority of H1N1 vaccine product assessments, shortening waits for testing and streamlining their path to the market.
It's better that clinical trials (for H7N9 vaccine products) start sooner because it takes ti